European Brachytherapy Market, Size, Share, Analysis Report & Forecast to 2026

The European brachytherapy market is anticipated to grow at a CAGR of 3.6% during the forecast period. According to the World Health Organization, Europe comprises only one-eighth of the total global population, however, has around one-quarter of the global total of cancer cases with some 3.7 million new patients per year. The factors driving the market growth include the increasing number of cancer patients, reduction in the cost of radiotherapy, and rising government and non-government investments in R&D of cancer treatment.

Free Sample Copy @ https://www.omrglobal.com/request-sample/europe-brachytherapy-market

The European brachytherapy market is segmented based on indication and type. Based on indication, the brachytherapy market is segmented into breast cancer, gynecological cancer, prostate cancer, skin cancer, brain cancer, and others. Prostate cancer held a major share in the region as according to the American Cancer Society, 1 in 9 men are likely to be diagnosed with prostate cancer during their lifetime. While 1 in 39 men dies with this disease. Based on type, the brachytherapy market is segmented into LDR and HDR. Geographically market is segmented into the UK, Germany, Italy, Spain, France, and the Rest of Europe. The UK dominated the market in terms of value.

A Full Report of European Brachytherapy Market is Available at:
https://www.omrglobal.com/industry-reports/europe-brachytherapy-market

The market study of the European brachytherapy market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

European Brachytherapy Market – Segmentation
by Indication
Breast Cancer
Gynecological Cancer
Prostate Cancer
Skin Cancer
Brain Cancer
Others
by Type
Low-Dose Rate (LDR) Brachytherapy
High-Dose Rate (HDR) Brachytherapy

European Brachytherapy Market – Segmentation by Region 
Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Company Profiles
Carl Zeiss Meditec AG
CIVCO Medical Solutions
Eckert & Ziegler BEBIG
ELEKTA AB
Ion Beam Applications S.A.
RaySearch Laboratories AB
SeeDOS Ltd.
Siemens Healthineers AG

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/europe-brachytherapy-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com 
Contact no: +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.